Welcome to
US Medical Affairs
Cardiorenal
Start Exploring
Welcome to Bayer’s Medical Affairs Cardiorenal platform focusing on chronic kidney disease (CKD) associated with type 2 diabetes (T2D).
CKD is one of the most frequent complications arising from diabetes and is an independent risk factor of cardiovascular disease. CKD associated with T2D is the most common cause of kidney failure worldwide.
With early intervention being associated with a better prognosis for these patients, at Bayer, we are committed to advancing awareness, knowledge, and therapeutic options for CKD associated with T2D. We invite you to explore educational resources and information on this website.
You are encouraged to report side effects or quality complaints of products to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088. For Bayer products, you can report these directly to Bayer by clicking here.
This site provides access to balanced and evidence-based medical information related to our therapeutic areas of focus and is intended to serve as a medical resource for US HCPs. This may include investigational compounds or investigational new uses of FDA-approved Bayer products. The information provided is not intended to be promotional or provide medical advice. Please refer to the full Prescribing Information for approved indications, contraindications, warnings and precautions, and adverse events.
